Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Megan Brooks

    News

    FDA OKs new treatment for erosive esophagitis

    Author:
    Megan Brooks
    Publish date: November 3, 2023

    Vonoprazan provides clinicians with a “new first-in-class therapeutic option that demonstrated faster healing in the more difficult-to-treat GERD...

    • Read More

    News

    Does diabetes affect colorectal cancer outcomes?

    Author:
    Megan Brooks
    Publish date: November 2, 2023

    “Preventing diabetes complications may help improve survival in patients with CRC, especially [in] female patients and those in the early stages...

    • Read More

    News

    More evidence metformin may be neuroprotective

    Author:
    Megan Brooks
    Publish date: November 1, 2023

    Adults who stopped metformin early were 21% more likely to be diagnosed with dementia during follow-up.

    • Read More

    News

    Urgent need to improve early detection of mild cognitive impairment in primary care

    Author:
    Megan Brooks
    Publish date: October 31, 2023

    More than 99% of clinicians and practices underdiagnosed MCI; clinicians practicing geriatric medicine had higher detection rates than others.

    • Read More

    News

    FDA okays drug for Duchenne muscular dystrophy

    Author:
    Megan Brooks
    Publish date: October 30, 2023

    The approval of vamorolone “provides people living with Duchenne, and their families, a powerful tool to treat the disease, while limiting some...

    • Read More

    News

    Experts question finding that 70% cancer deaths are preventable

    Author:
    Megan Brooks
    Publish date: October 30, 2023

    The findings represent a snapshot of premature mortality in 2020 but do not necessarily predict progress in cancer control over time.

    • Read More

    News

    FDA approves mirikizumab for ulcerative colitis

    Author:
    Megan Brooks
    Publish date: October 27, 2023

    It’s the first IL-23 inhibitor to be approved in the United States for UC.

    • Read More

    News

    Promising topline phase 2 results for novel oral Alzheimer’s drug

    Author:
    Megan Brooks
    Publish date: October 26, 2023

    The data suggest that a “high plasma pTau-217/non–pTau-217 ratio, a marker of AD pathology, likely defines an AD population responsive to T3D-959...

    • Read More

    News

    Telehealth linked to better opioid treatment retention

    Author:
    Megan Brooks
    Publish date: October 26, 2023

    There was no increased risk of nonfatal overdose with telehealth treatment.

    • Read More

    News

    Orthostatic hypotension no deterrent to hypertension treatment

    Author:
    Megan Brooks
    Publish date: October 26, 2023

    Intensive antihypertensive treatment provides the same benefit for cardiovascular disease and all-cause mortality regardless of orthostatic or...

    • Read More

    News

    Pandemic-era telehealth led to fewer therapy disruptions

    Author:
    Megan Brooks
    Publish date: October 26, 2023

    After the onset of the pandemic, more than half of psychotherapy visits (51.8%) were virtual.

    • Read More

    News

    The sobering facts about alcohol and cancer

    Author:
    Megan Brooks
    Publish date: October 25, 2023

    An ESMO session highlights the well-known links between alcohol consumption and cancer and calls on healthcare professionals to do more to raise...

    • Read More

    News

    Hitting the snooze button may provide cognitive benefit

    Author:
    Megan Brooks
    Publish date: October 25, 2023

    “There is no reason to stop snoozing in the morning if you enjoy it, at least not for snooze times around 30 minutes.”

    • Read More

    News

    FDA okays first extravascular ICD system

    Author:
    Megan Brooks
    Publish date: October 25, 2023

    “Placing the leads outside of the heart, rather than inside the heart and veins, reduces the risk of long-term complications ...”

    • Read More

    News

    Study reveals potentially unnecessary CRC screening in older adults

    Author:
    Megan Brooks
    Publish date: October 25, 2023

    “Personalized screening incorporating individual life expectancy may improve the value of screening.”

    • Read More

    Pages

    • « first
    • …
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery